全球大佬财富轨迹追踪
Serenity(白毛股神)
Serenity (@aleabitoreddit)Serenity(白毛股神)@aleabitoreddit发帖2026-06-22

作者讨论了在产能爬坡前的小型设备垄断企业,重点提及LPKF作为玻璃基板核心供应商,拥有高客户占有率。

作者讨论了在产能爬坡前的小型设备垄断企业,重点提及LPKF作为玻璃基板核心供应商,拥有高客户占有率。

As for $LPK: Maybe $3B-$5B seems reasonable when they fully volume ramp if I had to guess. Feels more asymmetrical to me personally since it's just a waiting game and they have the customers for glass substrates. Small machine supplier chokepoints usually cap out from TAM though and don't go to $20B+ unless you're ASML or hold many chokepoints like KLAC. Not many dominant "monopolies" like these out there right before volume ramp this small: Maybe you have stuff like: - Aixtron (MOCVD) ~$8B - Towa (compression bonding) ~$2B - Techwing (memory handler/cube probes) ~$1.5B - MSScorps (CPO inspection), but pre-ramp. $850M - Riber (quantum MBE), very pre-ramp ~$350M Then LPK Laser for glass core substrates (about to ramp) at ~$730M, which thematically should have more premiums than memory. (eg. major advanced packaging shift, CPO adjacent, etc). Lot of obscure chemical monopolies I know of, but those don't get as much attention cause BOM is much lower than equipment. But for lpk you have: eg. “80% of customers among major global players have selected LPKF equipment”. 70% of LIDE market share target for TGV in the glass-core ramp, should be very material. (disclosure: own, the listed names above aside from techwing/aixtron, NFI). Just kinda the path they go if you follow $AEHR at ~$3.5B now: - <$500m: "Oh they have no customers!" ---> (probably somewhere in the middle here). - < $1.5B: "Maybe volume comes soon!" - $3B+ onward: "Looks like they're starting to volume ramp. Just a lesson for the cycle of the chokepoint machine suppliers from my personal experiences.
原帖X / @aleabitoreddit

关联股票

LPK看多

80%的全球主要客户选择了LPKF设备;玻璃基板TGV市场中LIDE份额目标70%;市值较小,预期溢价高于存储器供应商。

去交易
AIXTRON关注

被列为可比的小型垄断公司(MOCVD),但未直接分析。

去交易
TOWA关注

被提及为压缩键合环节的瓶颈公司,市值约20亿美元,但无新分析。

去交易
AEHR看多
-1.98% 今日
+202.13% 90天

作为历史案例,展示小型设备垄断企业在产能爬坡期间的市值重估(从不到5亿美元升至35亿美元)。

去交易
仅供参考 · 风向标是信息工具,不构成投资建议,不推荐买卖任何证券。行程可能基于官方确认前的媒体报道。公开战绩存在幸存者偏差。投资决策与责任由您自行承担。